When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BBIO - Eidos up 13% on sustained benefit of AG10 in ATTR-CM
BridgeBio Pharma Inc.
Eidos Therapeutics (EIDX+13%) announces positive data from the ongoing open-label extension (OLE) of a Phase 2 study evaluating AG10 in patients with symptomatic transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM). The results were presented at the American Heart Association Scientific Sessions in Philadelphia.
More news on: BridgeBio Pharma, Inc., Eidos Therapeutics, Inc., Healthcare stocks news, Stocks on the move,